APA (7th ed.) Citation

Maamar Kara, Omar Aitmokhtar, Adel Azaza, Saber Seddiki, Faiza Harbi, Arezki Sik, . . . Salim Benkhedda. (2016). Does Rivaroxaban Better than Vitamin K Antagonists in Atrial Fibrillation Patients Undergoing PCI? Archives of Hematology Case Reports and Reviews - Peertechz Publications. https://doi.org/10.17352/ahcrr.000003

Chicago Style (17th ed.) Citation

Maamar Kara, Omar Aitmokhtar, Adel Azaza, Saber Seddiki, Faiza Harbi, Arezki Sik, Kheireddine Merad, and Salim Benkhedda. Does Rivaroxaban Better than Vitamin K Antagonists in Atrial Fibrillation Patients Undergoing PCI? Archives of Hematology Case Reports and Reviews - Peertechz Publications, 2016. https://doi.org/10.17352/ahcrr.000003.

MLA (9th ed.) Citation

Maamar Kara, et al. Does Rivaroxaban Better than Vitamin K Antagonists in Atrial Fibrillation Patients Undergoing PCI? Archives of Hematology Case Reports and Reviews - Peertechz Publications, 2016. https://doi.org/10.17352/ahcrr.000003.